Knockdown of LINC00461 suppressed glioma cell proliferation, migration, invasion, and TMZ resistance in U251 and A172 cells in vitro and inhibited tumor growth in vivo through targeting miR-216a and downregulating AQP4. The gene discussed is MIR9-2HG; the disease is central nervous system cancer.